New study sheds light on interferon combinations’ role in lupus variability

FHS
May 14, 2024
6:17 pm

In a new study, researchers from Johns Hopkins Medicine say they have uncovered insights as to why lupus symptoms and severity present differently in individuals with the autoimmune condition, which affects up to 1.5 million Americans.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Combining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly improved event-free survival (EFS) compared with the standard treatment of ATRA and anthracycline-based

June 18, 2024

Biden’s Doc Says No Parkinson’s; Overlooked COVID Symptom; STDs Spiked Among Seniors

Note that some links may require registration or subscription. President Joe Biden has not seen a neurologist outside of his annual physical and his last

July 10, 2024

Natural Medicine Advisory Bulletin 12: May and June 2024 – Psychedelic Alpha

Facilitator Licensing & Training DORA’s first set of rules, released in April, mark the first rules for Colorado’s regulated Natural Medicine program to become official.

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.